PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis
NCT00547976 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2012-04-27
Summary
Inflammation in the vascular wall is important in atherosclerosis and the blockage of the artery. The peripheral benzodiazepine receptor is involved in inflammation and in this protocol we will attempt to take pictures, using PET camera, of inflammation in patients with atherosclerosis and compare those of healthy people.
Conditions
- Atherosclerosis
- Healthy
Interventions
- DRUG
-
[C-11]PBR28
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2009-08-31
- Completion
- 2009-08-31
Countries
- United States
Study Locations
More Related Trials
-
Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis
NCT00432900 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging Inflammation in Alzheimer's Disease
NCT02831283 ·Status: COMPLETED ·Phase: PHASE2
-
PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand
NCT03958630 ·Status: TERMINATED ·Phase: PHASE1
-
PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram
NCT00250172 ·Status: COMPLETED ·Phase: PHASE1
-
Molecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases
NCT06731842 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
CANF-Comb-II PET-MR in Atherosclerosis Multisite
NCT05838547 ·Status: RECRUITING
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
NCT04396873 ·Status: RECRUITING ·Phase: PHASE1
-
Imaging Blood Brain Imaging Dysfunction in Parkinson's Disease
NCT02605161 ·Status: COMPLETED
-
Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease
NCT04057807 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Molecular Imaging of Plaque Vulnerability
NCT02640313 ·Status: RECRUITING ·Phase: PHASE3
-
Phase 1 Test-retest Evaluation of [18F]MNI-958 PET
NCT03545789 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers
NCT01009359 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers
NCT06874205 ·Status: RECRUITING ·Phase: PHASE1
-
Supplementing Neuro-Energy to Aid Cognition
NCT06767124 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assess Fibrin in Brains With AD/ADRD
NCT05336695 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NCT01209156 ·Status: COMPLETED ·Phase: PHASE1
-
Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease
NCT03307993 ·Status: TERMINATED ·Phase: PHASE1
-
Imaging Biomarkers of Neuroplasticity and Neurodegeneration in the Living Human Brain
NCT05427656 ·Status: UNKNOWN ·Phase: PHASE1
-
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
NCT04786223 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers
NCT01826110 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury
NCT05337774 ·Status: TERMINATED ·Phase: PHASE1
-
18F-Flutemetamol and Plaque Vulnerability
NCT03291093 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Synaptic Density, Tau and Multiparametric PET-MR in Brain Trauma, Stroke and Mild Cognitive or Behavioral Impairment.
NCT03514524 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)
NCT02062099 ·Status: COMPLETED ·Phase: PHASE1
-
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
NCT05582200 ·Status: RECRUITING